ASPHD2 and tuberculosis: Notably, ASPHD2 expression exhibited a marked decline following one month of anti-tuberculosis treatment (d = −2.08), underscoring its potential utility as a dynamic biomarker for monitoring therapeutic response in tuberculosis.